在瘤发生和癌症治疗中的SEPT9_i1和septin动力学
Piotr Jędrzejczak1, Kamil Saramowicz1, Justyna Kuś1
1Department of Clinical Chemistry and Biochemistry, Medical University of Lodz, 90-419 Lodz, Poland.
Biomolecules
|September 28, 2024
概括
9月9号 (SEPT9),特别是SEPT9_i1异型,驱动癌症的进展和耐治疗性. 抑制隔膜,就像福克洛芬uron一样,提供了作为新的癌症疗法和迁移药物的潜力.
科学领域:
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
- 生物化学 生物化学
背景情况:
- 癌症仍然是一个重要的医疗保健挑战,尽管有进展.
- 细胞骨在癌症的发展中起着至关重要的作用.
- 七是一种GTP结合蛋白的类别,形成细胞骨架的第四个组成部分.
研究的目的:
- 审查9月9号病毒 (SEPT9) 和其SEPT9_i1异型的结构和相互作用.
- 阐明SEPT9_i1致癌性的机制基础.
- 讨论 septin 抑制剂作为癌症治疗药物的潜力.
主要方法:
- 文献综述侧重于SEPT9和SEPT9_i1的结构和功能.
- 分析SEPT9_i1与低氧诱导因子α (HIF-1α) 和C-Jun N-终端激酶 (JNK) 的相互作用.
- 讨论SEPT9_i1在阳性积分,细胞侵入性和分类物耐药性中的作用.
主要成果:
- SEPT9是结直肠癌 (CRC) 的生物标志物,与其他癌症的晚期相对应.
- 这种SEPT9_i1异型对致癌,转移和治疗耐药性有显著的贡献.
- SEPT9_i1影响了关键的癌症进展现象,如体积和侵入性.
结论:
- SEPT9和SEPT9_i1对于癌症的发展和进展至关重要.
- 了解SEPT9_i1的致癌机制至关重要.
- 七抑制剂,如福克洛芬,作为化疗药物和迁移药物表现有前途.
相关概念视频
Role of Septins
1.7K
Septins are the recently discovered fourth major protein component of the cytoskeleton, along with microfilaments, microtubules, and intermediate filaments. These proteins can associate with other cytoskeletal filaments and carry out varied roles or can be free-floating in the cytoplasm.
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
Cellular Functions of Septins
Recent studies have revealed the multifaceted roles of septins in various cellular processes such as cytokinesis, ciliogenesis, and neurogenesis. Septins act as scaffolds and...
1.7K
Septins
1.8K
Septins are protein filaments forming the cytoskeleton along with the microtubules, microfilaments, intermediate filaments, and other accessory proteins. In 1971 while studying the cell division cycle in mutant Saccharomyces cerevisiae Harwell et al. first identified the septin-related genes playing a crucial role in yeast cytokinesis. Fluorescence microscopy revealed that these proteins localize at the budding neck as rings. These ring-like proteins were then named Septins by John Pringle, and...
1.8K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Cancer-Critical Genes II: Tumor Suppressor Genes
7.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.3K
Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K


